Please assess the completion status of the following clinical trial:

Trial Title: Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003)

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Good physical health~* Has never had Papanicolaou testing (Pap, cervical or anal) or has only had normal Pap test results~* Other inclusion criteria will be discussed with the investigator~Exclusion Criteria:~* History of severe allergic reaction that required medical intervention~* Currently enrolled in a clinical trial~* If participant is female, pregnant~* Currently immunocompromised or having received immunosuppressive therapy in the last year~* Positive test for HPV~* History of HPV-related external genital lesions or HPV-related anal lesions or anal cancer~* If participant is female, history of abnormal cervical biopsy results~* Other exclusion criteria will be discussed with the investigator

- Gender: ALL
- Minimum Age: 16 Years
- Maximum Age: 26 Years
- Healthy Volunteers: t

Study Arms:
- Females (Type: ACTIVE_COMPARATOR): Healthy females 16 to 26 years of age received 9vHPV vaccine 0.5 mL intramuscular injection on Day 1, Month 2, and Month 6
- Heterosexual Males (Type: EXPERIMENTAL): Healthy heterosexual males 16 to 26 years of age received 9vHPV 0.5 mL intramuscular injection on Day 1, Month 2, and Month 6
- Men who have Sex with Men (Type: EXPERIMENTAL): Healthy MSM 16 to 26 years of age received 9vHPV 0.5 mL intramuscular injection on Day 1, Month 2, and Month 6

Based on this trial design, predict the completion outcome and termination type (if applicable).